Home

Domain Partners VI, L.P.

CIK 1298033 · last filed 2016-11-03

Domain Partners VI, L.P. is a corporate insider who has filed 19 SEC Form 4 insider transactions across 6 companies since 2008. Across all open-market trades the lifetime net is −$8.9M, making them a net seller over the disclosed history. The firm reports its address in Princeton, NJ. 40 SEC filings were submitted jointly with JAMES C BLAIR.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

6

Total Filings

19

Lifetime Open-Market Net

-$8.88M

Filer Profile

Reported Address
ONE PALMER SQUARE
PRINCETON, NJ 08542
Phone
(609) 683-5656
State of Incorporation
DE
Related Filers
JAMES C BLAIR — 40 joint filings, latest 2017-12-13
BRIAN H DOVEY — 40 joint filings, latest 2017-12-13
JESSE I TREU — 40 joint filings, latest 2017-12-13
NICOLE VITULLO — 40 joint filings, latest 2017-12-13
KATHLEEN K SCHOEMAKER — 33 joint filings, latest 2015-05-11
DOMAIN PARTNERS V LP — same reported address
DP V ASSOCIATES LP — same reported address
DP VI Associates, L.P. — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CoLucid Pharmaceuticals, Inc. (CLCD) Delisted 10%+ Owner 2,096,137 — — -$5.21M 1 2016-05-02
Tobira Therapeutics, Inc. (RGDO) Delisted 10%+ Owner 202,346 — — $3.00M 1 2013-08-28
Ocera Therapeutics, Inc. (TZYM) Delisted 10%+ Owner 1,897,336 — — $2.00M 1 2013-07-16
ALIMERA SCIENCES INC (ALIM) Delisted 10%+ Owner 272,369 $5.54 $1.51M $2.94M 3 2013-05-17
CADENCE PHARMACEUTICALS INC (CADX) Delisted 10%+ Owner 7,313,241 — — -$11.61M 9 2013-04-17
ZOGENIX, INC. (ZGNX) Delisted 10%+ Owner 1,237 $26.68 $33.0K $0 1 2010-12-01

Recent Filings

19 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2016-11-03 — U −1,428,395 -$40.49M
2016-05-02 CoLucid Pharmaceuticals, Inc. (CLCD) Delisted Sell (S) −748,825 -$5.21M EDGAR
2014-03-21 — Disp (D) −7,313,241 -$102.39M
2013-08-28 Tobira Therapeutics, Inc. (RGDO) Delisted Mixed +2,535,570 $3.00M EDGAR
2013-07-31 — Buy (P) +331,873 $2.00M
2013-07-16 Ocera Therapeutics, Inc. (TZYM) Delisted Buy (P) +331,873 $2.00M EDGAR
2013-05-17 ALIMERA SCIENCES INC (ALIM) Delisted Sell (S) −265,452 -$1.22M EDGAR
2013-04-17 CADENCE PHARMACEUTICALS INC (CADX) Delisted Sell (S) −429,468 -$2.84M EDGAR
2013-03-15 CADENCE PHARMACEUTICALS INC (CADX) Delisted Sell (S) −235,968 -$1.27M EDGAR
2013-03-11 CADENCE PHARMACEUTICALS INC (CADX) Delisted Sell (S) −330,360 -$1.73M EDGAR
Showing 1–10 of 19
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.